about
Hereditary thrombophiliaMethods for high-density admixture mapping of disease genesInflammatory bowel disease and thrombosisActivated protein C anticoagulant system dysfunction and thrombophilia in AsiaReview article: Venous thromboembolism after total joint replacementDiagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice GuidelinesReview article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.Initial imaging analysis of Budd-Chiari syndrome in Henan province of China: most cases have combined inferior vena cava and hepatic veins involvement.Recent advances in haematology.Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosisIncreased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors.Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.Venous thromboembolism in paediatric practice.Development of a rapid DNA screening procedure for the Factor V Leiden mutationThe multigenic basis for venous thrombosis.Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerResistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.Thrombophilia in pregnancy.Factor V Leiden thrombophilia.Pregnancy loss and thrombophilia: the elusive link.Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery.Variants associated with common disease are not unusually differentiated in frequency across populations.Global distribution of the CCR5 gene 32-basepair deletion.Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelinePrevalence of the factor V-Leiden mutation in four distinct American ethnic populations.Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice.Laboratory thrombophilias and venous thromboembolism.Pharmacogenomics in anticoagulant drug development.A Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR) for the Detection of Factor V Leiden and Prothrombin G20210A.Risk of Budd-Chiari syndrome associated with factor V Leiden and G20210A prothrombin mutation: a meta-analysis.Review article: inherited thrombophilia in inflammatory bowel disease.Activated protein C resistance in patients with central retinal vein occlusion.Pathophysiology of the antiphospholipid antibody syndrome.Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.Genetics and pulmonary medicine. 4. Pulmonary embolismDeep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty.Combined oral contraceptives, smoking, and cardiovascular risk.Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic strokeHigh Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region.
P2860
Q21093254-5A0D3834-D963-4A9C-9D4C-10BE4E5ED679Q22337164-B7D9810A-7B6B-4BA2-8207-7DA6034A6F60Q26830337-71F2D6B5-7BAE-43AC-AEBE-66565604BCE0Q26865139-CD0425A4-ADE2-4A2E-9BAA-E1DE0C224640Q27006824-C914BFB5-146F-48D0-A9B4-C5D5C22738A1Q28072833-EC000D43-CFAC-4FBB-9DDF-BD5D407627ADQ30244631-BB49729C-3BCE-4F18-9CD3-9718BED29A10Q30444566-6EEA3C36-8BA7-4DB5-A9C9-0A00C50A1B64Q33589742-70FD4FE7-A334-4084-B08B-156B3B0C7799Q33618227-C60EE7EA-506C-44A1-AE9B-9DAA5C42CD4BQ33780732-9B999B5F-8E7F-45C2-A712-DC9A30078D3BQ33789475-405155D3-D63C-445F-B7C2-EC1EBD13421BQ33794116-ADD0E0B3-9105-4917-BB69-7EC811C80DF5Q33842391-C6EC1B7B-5BD1-4C57-BDD1-740D6304117CQ33962060-F973C9EB-0435-4C79-8B7B-DEF864F02DD4Q33965106-29937BD5-8269-40A1-ABD0-6C0715B9AB44Q34013076-9BDA5FF4-605F-4C46-95C0-23A1719DD258Q34043661-EC0077E3-0073-4CAE-85BC-CEFED5F453F5Q34152374-1108812A-FE3D-4277-B6A2-A52F620BA0A8Q34263740-548CFFCC-F67D-4406-B1EA-FD217DE6F5CDQ34354764-C0E70DD1-655A-453B-8E54-26B6E01FF343Q34398712-06273A16-736C-4690-9EAE-33A5ADE4E562Q34425080-10477F9F-B2E4-4B31-A417-D97EE344D7D4Q34425513-13D052A2-8129-4004-97A9-C0EA8CBB9F99Q34450894-F12F8518-963C-4B05-AB1B-1FFAEA8F986DQ34659598-724DF042-BE79-4EBA-8318-29779B78C6FDQ34981644-6FB8708D-B9A1-4EC6-AB48-84A4B34878A6Q35000929-71C6A1E3-87B0-4756-8FBF-5054AAB73181Q35146858-6FFDD9AC-D9C0-419D-AB6C-BF17616B0424Q35154859-407E3F7D-2941-41A1-AF7A-608953228E6AQ35158989-1F228C78-8761-49DD-8A56-B30F5742C4B3Q35298277-69C6D5E0-68F5-4153-9E26-470F33078C8DQ35309024-45BAF0C8-F232-4C3A-B36F-09B58907242CQ35369291-0B80FC3C-6ADE-4008-AF51-1DC614EDD29EQ35532628-16246083-888F-4718-9559-D31EEFE77F03Q35534057-31E37843-5D47-4A76-AF43-2AA5FB3CCCE8Q35558094-E8D62009-AE0C-43A6-8576-61B197290D0DQ35560338-3159972F-5419-481D-B068-EB15BA6177E8Q35606860-CD0B14AA-A762-4D6C-8E91-D22FFE47C4BFQ35640739-0DC73049-CBFC-4700-B772-832FC620C4DD
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
World distribution of factor V Leiden.
@ast
World distribution of factor V Leiden.
@en
World distribution of factor V Leiden.
@nl
type
label
World distribution of factor V Leiden.
@ast
World distribution of factor V Leiden.
@en
World distribution of factor V Leiden.
@nl
prefLabel
World distribution of factor V Leiden.
@ast
World distribution of factor V Leiden.
@en
World distribution of factor V Leiden.
@nl
P2093
P1433
P1476
World distribution of factor V Leiden.
@en
P2093
P304
P356
10.1016/S0140-6736(95)91803-5
P407
P577
1995-10-01T00:00:00Z